{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:23:54Z","timestamp":1790839434342,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003810","name":"Hospital de Cl\u00ednicas de Porto Alegre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003810","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>In this study, the prevalence of different types of mucopolysaccharidoses (MPS) was estimated based on data from the exome aggregation consortium (ExAC) and the genome aggregation database (gnomAD). The population-based allele frequencies were used to identify potential disease-causing variants on each gene related to MPS I to IX (except MPS II).\n<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We evaluated the canonical transcripts and excluded homozygous, intronic, 3\u2032, and 5\u2032 UTR variants. Frameshift and in-frame insertions and deletions were evaluated using the SIFT Indel tool. Splice variants were evaluated using SpliceAI and Human Splice Finder 3.0 (HSF). Loss-of-function single nucleotide variants in coding regions were classified as potentially pathogenic, while synonymous variants outside the exon\u2013intron boundaries were deemed non-pathogenic. Missense variants were evaluated by five in silico prediction tools, and only those predicted to be damaging by at least three different algorithms were considered disease-causing.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The combined frequencies of selected variants (ranged from 127 in <jats:italic>GNS<\/jats:italic> to 259 in <jats:italic>IDUA<\/jats:italic>) were used to calculate prevalence based on Hardy\u2013Weinberg's equilibrium. The maximum estimated prevalence ranged from 0.46 per 100,000 for MPSIIID to 7.1 per 100,000 for MPS I. Overall, the estimated prevalence of all types of MPS was higher than what has been published in the literature. This difference may be due to misdiagnoses and\/or underdiagnoses, especially of the attenuated forms of MPS. However, overestimation of the number of disease-causing variants by in silico predictors cannot be ruled out. Even so, the disease prevalences are similar to those reported in diagnosis-based prevalence studies.\n<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>We report on an approach to estimate the prevalence of different types of MPS based on publicly available population-based genomic data, which may help health systems to be better prepared to deal with these conditions and provide support to initiatives on diagnosis and management of MPS.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13023-020-01608-0","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T06:03:32Z","timestamp":1605679412000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Estimated prevalence of mucopolysaccharidoses from population-based exomes and genomes"],"prefix":"10.1186","volume":"15","author":[{"given":"P\u00e2mella","family":"Borges","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Pasqualim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giugliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6030-1903","authenticated-orcid":false,"given":"Filippo","family":"Vairo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Matte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,18]]},"reference":[{"issue":"5","key":"1608_CR1","doi-asserted-by":"publisher","first-page":"v4","DOI":"10.1093\/rheumatology\/ker394","volume":"50","author":"J Muenzer","year":"2011","unstructured":"Muenzer J. Overview of the mucopolysaccharidoses. Rheumatology (Oxford). 2011;50(5):v4\u201312. https:\/\/doi.org\/10.1093\/rheumatology\/ker394.","journal-title":"Rheumatology (Oxford)."},{"issue":"Suppl 4","key":"1608_CR2","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1590\/s1415-47572012000600006","volume":"35","author":"R Giugliani","year":"2012","unstructured":"Giugliani R. Mucopolysacccharidoses: From understanding to treatment, a century of discoveries. Genet Mol Biol. 2012;35(Suppl 4):924\u201331. https:\/\/doi.org\/10.1590\/s1415-47572012000600006.","journal-title":"Genet Mol Biol"},{"issue":"24","key":"1608_CR3","doi-asserted-by":"publisher","first-page":"476","DOI":"10.21037\/atm.2018.11.39","volume":"6","author":"A Sun","year":"2018","unstructured":"Sun A. Lysosomal storage disease overview. Ann Transl Med. 2018;6(24):476. https:\/\/doi.org\/10.21037\/atm.2018.11.39.","journal-title":"Ann Transl Med"},{"issue":"1","key":"1608_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1517\/14728214.2016.1123690","volume":"21","author":"R Giugliani","year":"2016","unstructured":"Giugliani R, Federhen A, Vairo F, et al. Emerging drugs for the treatment of mucopolysaccharidoses. Expert Opin Emerg Drugs. 2016;21(1):9\u201326. https:\/\/doi.org\/10.1517\/14728214.2016.1123690.","journal-title":"Expert Opin Emerg Drugs"},{"issue":"1","key":"1608_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00439-013-1358-4","volume":"133","author":"PD Stenson","year":"2014","unstructured":"Stenson PD, Mort M, Ball EV, Shaw K, Phillips A, Cooper DN. The human gene mutation database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet. 2014;133(1):1\u20139. https:\/\/doi.org\/10.1007\/s00439-013-1358-4.","journal-title":"Hum Genet"},{"issue":"2","key":"1608_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/ijns5020017","volume":"5","author":"BH Robinson","year":"2019","unstructured":"Robinson BH, Gelb MH. The importance of assay imprecision near the screen cutoff for newborn screening of lysosomal storage diseases. Int J Neonatal Screen. 2019;5(2):17. https:\/\/doi.org\/10.3390\/ijns5020017.","journal-title":"Int J Neonatal Screen"},{"issue":"2","key":"1608_CR7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/ijns3020006","volume":"3","author":"PCJI Schielen","year":"2017","unstructured":"Schielen PCJI, Kemper EA, Gelb MH. Newborn screening for lysosomal storage diseases: a concise review of the literature on screening methods, therapeutic possibilities and regional programs. Int J Neonatal Screen. 2017;3(2):6. https:\/\/doi.org\/10.3390\/ijns3020006.","journal-title":"Int J Neonatal Screen"},{"issue":"7616","key":"1608_CR8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek M, Karczewski KJ, Minikel EV, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536(7616):285\u201391. https:\/\/doi.org\/10.1038\/nature19057.","journal-title":"Nature"},{"key":"1608_CR9","doi-asserted-by":"publisher","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alf\u00f6ldi J, Wang Q, et al. Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes. bioRxiv. 2019;531210. Available from: https:\/\/www.biorxiv.org\/content\/https:\/\/doi.org\/10.1101\/531210v2","DOI":"10.1101\/531210v2"},{"issue":"4","key":"1608_CR10","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ymgme.2015.10.010","volume":"116","author":"V Appadurai","year":"2015","unstructured":"Appadurai V, DeBarber A, Chiang PW, et al. Apparent underdiagnosis of cerebrotendinous xanthomatosis revealed by analysis of ~60,000 human exomes. Mol Genet Metab. 2015;116(4):298\u2013304. https:\/\/doi.org\/10.1016\/j.ymgme.2015.10.010.","journal-title":"Mol Genet Metab"},{"issue":"9","key":"1608_CR11","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1093\/nar\/gkp215","volume":"37","author":"FO Desmet","year":"2009","unstructured":"Desmet FO, Hamroun D, Lalande M, Collod-B\u00e9roud G, Claustres M, B\u00e9roud C. Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 2009;37(9):e67. https:\/\/doi.org\/10.1093\/nar\/gkp215.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"1608_CR12","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","volume":"176","author":"K Jaganathan","year":"2019","unstructured":"Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF, et al. Predicting splicing from primary sequence with deep learning. Cell. 2019;176(3):535-548.e24. https:\/\/doi.org\/10.1016\/j.cell.2018.12.015.","journal-title":"Cell"},{"key":"1608_CR13","doi-asserted-by":"publisher","unstructured":"Hu J, Ng PC. SIFT Indel: predictions for the functional effects of amino acid insertions\/deletions in proteins. PLoS One. 2013;8(10):e77940. Published 2013 Oct 23; doi:https:\/\/doi.org\/10.1371\/journal.pone.0077940","DOI":"10.1371\/journal.pone.0077940"},{"issue":"21","key":"1608_CR14","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1093\/bioinformatics\/btp528","volume":"25","author":"B Li","year":"2009","unstructured":"Li B, Krishnan VG, Mort ME, et al. Automated inference of molecular mechanisms of disease from amino acid substitutions. Bioinformatics. 2009;25(21):2744\u201350. https:\/\/doi.org\/10.1093\/bioinformatics\/btp528.","journal-title":"Bioinformatics"},{"issue":"4","key":"1608_CR15","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248\u20139. https:\/\/doi.org\/10.1038\/nmeth0410-248.","journal-title":"Nat Methods"},{"issue":"10","key":"1608_CR16","doi-asserted-by":"publisher","first-page":"e46688","DOI":"10.1371\/journal.pone.0046688","volume":"7","author":"Y Choi","year":"2012","unstructured":"Choi Y, Sims GE, Murphy S, Miller JR, Chan AP. Predicting the functional effect of amino acid substitutions and indels. PLoS ONE. 2012;7(10):e46688. https:\/\/doi.org\/10.1371\/journal.pone.0046688.","journal-title":"PLoS ONE"},{"issue":"7","key":"1608_CR17","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/nprot.2009.86","volume":"4","author":"P Kumar","year":"2009","unstructured":"Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4(7):1073\u201381. https:\/\/doi.org\/10.1038\/nprot.2009.86.","journal-title":"Nat Protoc"},{"issue":"4","key":"1608_CR18","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","volume":"99","author":"NM Ioannidis","year":"2016","unstructured":"Ioannidis NM, Rothstein JH, Pejaver V, et al. REVEL: an Ensemble method for predicting the pathogenicity of rare missense variants. Am J Hum Genet. 2016;99(4):877\u201385. https:\/\/doi.org\/10.1016\/j.ajhg.2016.08.016.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"1608_CR19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/cge.13583","volume":"96","author":"LA Clarke","year":"2019","unstructured":"Clarke LA, Giugliani R, Guffon N, et al. Genotype-phenotype relationships in mucopolysaccharidosis type I (MPS I): Insights from the International MPS I registry. Clin Genet. 2019;96(4):281\u20139. https:\/\/doi.org\/10.1111\/cge.13583.","journal-title":"Clin Genet"},{"issue":"3","key":"1608_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ymgme.2017.05.016","volume":"121","author":"SA Khan","year":"2017","unstructured":"Khan SA, Peracha H, Ballhausen D, et al. Epidemiology of mucopolysaccharidoses. Mol Genet Metab. 2017;121(3):227\u201340. https:\/\/doi.org\/10.1016\/j.ymgme.2017.05.016.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"1608_CR21","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/ajmg.a.61456","volume":"182","author":"A Federhen","year":"2020","unstructured":"Federhen A, Pasqualim G, de Freitas TF, et al. Estimated birth prevalence of mucopolysaccharidoses in Brazil. Am J Med Genet A. 2020;182(3):469\u201383. https:\/\/doi.org\/10.1002\/ajmg.a.61456.","journal-title":"Am J Med Genet A"},{"issue":"7","key":"1608_CR22","doi-asserted-by":"publisher","first-page":"e0200008","DOI":"10.1371\/journal.pone.0200008","volume":"13","author":"WT Clark","year":"2018","unstructured":"Clark WT, Yu GK, Aoyagi-Scharber M, LeBowitz JH. Utilizing ExAC to assess the hidden contribution of variants of unknown significance to Sanfilippo Type B incidence. PLoS One. 2018;13(7):e0200008. https:\/\/doi.org\/10.1371\/journal.pone.0200008.","journal-title":"PLoS One."},{"issue":"D1","key":"1608_CR23","doi-asserted-by":"publisher","first-page":"D886","DOI":"10.1093\/nar\/gky1016","volume":"47","author":"P Rentzsch","year":"2019","unstructured":"Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 2019;47(D1):D886\u201394. https:\/\/doi.org\/10.1093\/nar\/gky1016.","journal-title":"Nucleic Acids Res"},{"key":"1608_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/8904_2015_467","volume":"25","author":"E Kiykim","year":"2016","unstructured":"Kiykim E, Barut K, Cansever MS, et al. Screening mucopolysaccharidosis Type IX in patients with juvenile idiopathic arthritis. JIMD Rep. 2016;25:21\u20134. https:\/\/doi.org\/10.1007\/8904_2015_467.","journal-title":"JIMD Rep"},{"issue":"6","key":"1608_CR25","doi-asserted-by":"publisher","first-page":"e20180658","DOI":"10.1542\/peds.2018-0658","volume":"142","author":"E Pinto","year":"2018","unstructured":"Pinto E, Vairo F, Conboy E, de Souza CFM, et al. Diagnosis of attenuated mucopolysaccharidosis VI: clinical, biochemical, and genetic pitfalls. Pediatrics. 2018;142(6):e20180658. https:\/\/doi.org\/10.1542\/peds.2018-0658.","journal-title":"Pediatrics"},{"issue":"Suppl 2","key":"1608_CR26","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13052-018-0551-4","volume":"44","author":"M Rigoldi","year":"2018","unstructured":"Rigoldi M, Verrecchia E, Manna R, Mascia MT. Clinical hints to diagnosis of attenuated forms of Mucopolysaccharidoses. Ital J Pediatr. 2018;44(Suppl 2):132. https:\/\/doi.org\/10.1186\/s13052-018-0551-4.","journal-title":"Ital J Pediatr"},{"issue":"Suppl 1","key":"1608_CR27","first-page":"159","volume":"12","author":"MS Sands","year":"2014","unstructured":"Sands MS. Mucopolysaccharidosis type VII: a powerful experimental system and therapeutic challenge. Pediatr Endocrinol Rev. 2014;12(Suppl 1):159\u201365.","journal-title":"Pediatr Endocrinol Rev"},{"issue":"9","key":"1608_CR28","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1002\/art.39659","volume":"68","author":"L Bonaf\u00e9","year":"2016","unstructured":"Bonaf\u00e9 L, Kariminejad A, Li J, et al. Brief report: peripheral osteolysis in adults linked to ASAH1 (Acid Ceramidase) mutations: a new presentation of farber\u2019s disease. Arthritis Rheumatol. 2016;68(9):2323\u20137. https:\/\/doi.org\/10.1002\/art.39659.","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"1608_CR29","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1002\/ajmg.a.37846","volume":"170","author":"SY Kim","year":"2016","unstructured":"Kim SY, Choi SA, Lee S, et al. Atypical presentation of infantile-onset farber disease with novel ASAH1 mutations. Am J Med Genet A. 2016;170(11):3023\u20137. https:\/\/doi.org\/10.1002\/ajmg.a.37846.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"1608_CR30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13023-018-0845-z","volume":"13","author":"FPS Yu","year":"2018","unstructured":"Yu FPS, Amintas S, Levade T, Medin JA. Acid ceramidase deficiency: farber disease and SMA-PME. Orphanet J Rare Dis. 2018;13(1):121. https:\/\/doi.org\/10.1186\/s13023-018-0845-z.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"1608_CR31","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.braindev.2018.01.009","volume":"40","author":"JS Lee","year":"2018","unstructured":"Lee JS, Choi JM, Lee M, et al. Diagnostic challenge for the rare lysosomal storage disease: late infantile GM1 gangliosidosis. Brain Dev. 2018;40(5):383\u201390. https:\/\/doi.org\/10.1016\/j.braindev.2018.01.009.","journal-title":"Brain Dev"},{"issue":"7","key":"1608_CR32","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.bbadis.2011.03.018","volume":"1812","author":"A Caciotti","year":"2011","unstructured":"Caciotti A, Garman SC, Rivera-Col\u00f3n Y, et al. GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings. Biochim Biophys Acta. 2011;1812(7):782\u201390. https:\/\/doi.org\/10.1016\/j.bbadis.2011.03.018.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"1608_CR33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10545-012-9533-7","volume":"36","author":"LM Pollard","year":"2013","unstructured":"Pollard LM, Jones JR, Wood TC. Molecular characterization of 355 mucopolysaccharidosis patients reveals 104 novel mutations. J Inherit Metab Dis. 2013;36(2):179\u201387. https:\/\/doi.org\/10.1007\/s10545-012-9533-7.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"1608_CR34","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/sj.ejhg.5200213","volume":"6","author":"S Bunge","year":"1998","unstructured":"Bunge S, Rathmann M, Steglich C, et al. Homologous nonallelic recombinations between the iduronate-sulfatase gene and pseudogene cause various intragenic deletions and inversions in patients with mucopolysaccharidosis type II. Eur J Hum Genet. 1998;6(5):492\u2013500. https:\/\/doi.org\/10.1038\/sj.ejhg.5200213.","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"1608_CR35","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ymgme.2013.08.011","volume":"111","author":"AC Brusius-Facchin","year":"2014","unstructured":"Brusius-Facchin AC, Schwartz IV, Zimmer C, et al. Mucopolysaccharidosis type II: identification of 30 novel mutations among Latin American patients. Mol Genet Metab. 2014;111(2):133\u20138. https:\/\/doi.org\/10.1016\/j.ymgme.2013.08.011.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"1608_CR36","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ymgme.2016.05.003","volume":"118","author":"M Kosuga","year":"2016","unstructured":"Kosuga M, Mashima R, Hirakiyama A, et al. Molecular diagnosis of 65 families with mucopolysaccharidosis type II (Hunter syndrome) characterized by 16 novel mutations in the IDS gene: Genetic, pathological, and structural studies on iduronate-2-sulfatase. Mol Genet Metab. 2016;118(3):190\u20137. https:\/\/doi.org\/10.1016\/j.ymgme.2016.05.003.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"1608_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13023-016-0558-0","volume":"12","author":"MA Chiong","year":"2017","unstructured":"Chiong MA, Canson DM, Abacan MA, Baluyot MM, Cordero CP, Silao CL. Clinical, biochemical and molecular characteristics of Filipino patients with mucopolysaccharidosis type II - Hunter syndrome. Orphanet J Rare Dis. 2017;12(1):7. https:\/\/doi.org\/10.1186\/s13023-016-0558-0.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"1608_CR38","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/cge.12927","volume":"91","author":"L Dvorakova","year":"2017","unstructured":"Dvorakova L, Vlaskova H, Sarajlija A, et al. Genotype-phenotype correlation in 44 Czech, Slovak, Croatian and Serbian patients with mucopolysaccharidosis type II. Clin Genet. 2017;91(5):787\u201396. https:\/\/doi.org\/10.1111\/cge.12927.","journal-title":"Clin Genet"},{"issue":"5","key":"1608_CR39","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00431-019-03341-8","volume":"178","author":"A Zanetti","year":"2019","unstructured":"Zanetti A, D\u2019Avanzo F, Rigon L, et al. Molecular diagnosis of patients affected by mucopolysaccharidosis: a multicenter study. Eur J Pediatr. 2019;178(5):739\u201353. https:\/\/doi.org\/10.1007\/s00431-019-03341-8.","journal-title":"Eur J Pediatr"},{"key":"1608_CR40","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.cca.2019.01.009","volume":"491","author":"W Zhang","year":"2019","unstructured":"Zhang W, Xie T, Sheng H, et al. Genetic analysis of 63 Chinese patients with mucopolysaccharidosis type II: Functional characterization of seven novel IDS variants. Clin Chim Acta. 2019;491:114\u201320. https:\/\/doi.org\/10.1016\/j.cca.2019.01.009.","journal-title":"Clin Chim Acta"},{"issue":"24","key":"1608_CR41","doi-asserted-by":"publisher","first-page":"100602","DOI":"10.1016\/j.ymgmr.2020.100602","volume":"5","author":"SG Kaler","year":"2020","unstructured":"Kaler SG, Ferreira CR, Yam LS. Estimated birth prevalence of Menkes disease and ATP7A-related disorders based on the Genome Aggregation Database (gnomAD). Mol Genet Metab Rep. 2020;5(24):100602. https:\/\/doi.org\/10.1016\/j.ymgmr.2020.100602.","journal-title":"Mol Genet Metab Rep"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01608-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-020-01608-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01608-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T06:12:26Z","timestamp":1605679946000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-01608-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,18]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1608"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-01608-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,18]]},"assertion":[{"value":"4 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No ethical approval was required.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and informed consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"324"}}